BriefCase

The BriefCase device employs an artificial intelligence algorithm to analyze cervical spine CT images, identifying suspected linear lucencies compatible with fractures to facilitate expedited radiologist review. Its purpose is to improve workflow triage by providing rapid notifications that significantly reduce the time to radiologist attention for potentially critical findings, operating as an adjunct to standard diagnostic procedures without altering them.

The BriefCase device is a radiological computer-aided triage and notification software designed for analyzing cervical spine CT images. Its primary purpose is to assist hospital networks and trained radiologists in optimizing workflow triage by identifying and communicating suspected positive findings of linear lucencies indicative of cervical spine fractures. The system employs an artificial intelligence algorithm to process images and flag cases with detected findings. These notifications, which include compressed, non-diagnostic preview images, are presented on a standalone desktop application, running in parallel with standard image interpretation. The device does not alter original medical images and is not intended for diagnostic use, but rather to guide prioritization of image review based on professional judgment and other patient information. A multicenter, retrospective, blinded study involving 186 cases demonstrated the BriefCase software's performance. It achieved a sensitivity of 91.7% and a specificity of 88.6% in identifying CTs containing cervical spine fractures. Furthermore, the study evaluated the device's potential to reduce the time for radiologists to review critical scans. For true positive cases, BriefCase provided notifications in an average of 3.9 minutes, significantly faster than the standard-of-care mean time-to-exam-open of 58.4 minutes, suggesting an average potential time saving of 54.4 minutes. The device's Negative Predictive Value (NPV) was 99.0% and its Positive Predictive Value (PPV) was 47.2%, indicating its utility in accelerating the review of potentially critical cases.

AI Regulatory Concerns

Powered by

Jev reads the full FDA letter and returns calibrated concern probabilities per regulatory category. These are AI estimates, not regulatory advice.

• Q1. How does the AI algorithm differentiate between true linear lucencies indicative of fractures and other artifacts or benign anatomical variants in cervical spine CTs?; What was the range of variability in 'time-to-exam-open' in the standard of care across the different clinical sites in the pivotal study, and how might this impact the generalizability of the reported time savings?; Given the Positive Predictive Value (PPV) of 47.2%, what is the anticipated impact on radiologist workload due to reviewing cases flagged by BriefCase that are ultimately negative for cervical spine fractures?; Were different types, locations, or severities of cervical spine fractures included in the study, and did the device's sensitivity vary significantly across these fracture characteristics?; How does the system handle variations in CT image quality or acquisition protocols, and what are the minimum image quality requirements for reliable algorithm performance?